Michael Don Hale

Title: Michael Don Hale: Innovator in Pharmacokinetic Drug Dosing Regimens

Introduction

Michael Don Hale is a notable inventor based in Winchester, MA (US). He has made significant contributions to the field of pharmacokinetics, particularly in drug dosing regimens. With a total of 3 patents to his name, Hale's work focuses on improving patient outcomes through innovative dosing strategies.

Latest Patents

Hale's latest patents include a method and apparatus for providing a pharmacokinetic drug dosing regimen. This invention outlines systems and methods for determining an estimated pharmacokinetic profile of a patient using a Bayesian model. The approach allows for the adjustment of dosing regimens based on previous patient treatments, ensuring that therapeutic plasma protein levels remain within target ranges. Another patent details a method for providing a clotting factor VIII dosing regimen, which involves collecting blood samples to determine clearance and half-life, ultimately leading to a tailored dosing regimen for patients.

Career Highlights

Throughout his career, Hale has worked with prominent companies in the pharmaceutical industry, including Baxalta GmbH and Takeda Pharmaceutical Company Limited. His experience in these organizations has allowed him to develop and refine his innovative approaches to drug dosing.

Collaborations

Hale has collaborated with several professionals in his field, including Kameswara Rao Kuchimanchi and Alexandra Loew-Baselli. These partnerships have contributed to the advancement of his research and the successful implementation of his inventions.

Conclusion

Michael Don Hale's contributions to pharmacokinetics and drug dosing regimens highlight his commitment to improving patient care through innovation. His patents and collaborations reflect a dedication to advancing medical science and enhancing treatment efficacy.